The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Antineoplastic Agents, Immunological.
Andrzej Jakubowiak
Connection Strength
0.644
Antineoplastic Agents, Immunological
  1. Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood Cancer J. 2021 05 26; 11(5):103.
    View in: PubMed
    Score: 0.644
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.